Continuous Glucose Monitoring in the Hospital
Continuous glucose monitors (CGMs) have suddenly become part of routine care in many hospitals. The coronavirus disease 2019 (COVID-19) pandemic has necessitated the use of new technologies and new processes to care for hospitalized patients, including diabetes patients. The use of CGMs to automatic...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Academya Publishing Co.
2021-04-01
|
Series: | Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.e-enm.org/upload/pdf/enm-2021-201.pdf |
id |
doaj-c25e4fe6964d4156a086017a31b918a7 |
---|---|
record_format |
Article |
spelling |
doaj-c25e4fe6964d4156a086017a31b918a72021-05-03T04:12:38ZengAcademya Publishing Co.Endocrinology and Metabolism2093-596X2093-59782021-04-0136224025510.3803/EnM.2021.2012146Continuous Glucose Monitoring in the HospitalM. Citlalli Perez-Guzman0Trisha Shang1Jennifer Y. Zhang2Donna Jornsay3David C. Klonoff4 Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University, Atlanta, GA, USA Diabetes Technology Society, Burlingame, CA, USA Diabetes Technology Society, Burlingame, CA, USA Diabetes Program, Mills-Peninsula Medical Center, Burlingame, CA, USA Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USAContinuous glucose monitors (CGMs) have suddenly become part of routine care in many hospitals. The coronavirus disease 2019 (COVID-19) pandemic has necessitated the use of new technologies and new processes to care for hospitalized patients, including diabetes patients. The use of CGMs to automatically and remotely supplement or replace assisted monitoring of blood glucose by bedside nurses can decrease: the amount of necessary nursing exposure to COVID-19 patients with diabetes; the amount of time required for obtaining blood glucose measurements, and the amount of personal protective equipment necessary for interacting with patients during the blood glucose testing. The United States Food and Drug Administration (FDA) is now exercising enforcement discretion and not objecting to certain factory-calibrated CGMs being used in a hospital setting, both to facilitate patient care and to obtain performance data that can be used for future regulatory submissions. CGMs can be used in the hospital to decrease the frequency of fingerstick point of care capillary blood glucose testing, decrease hyperglycemic episodes, and decrease hypoglycemic episodes. Most of the research on CGMs in the hospital has focused on their accuracy and only recently outcomes data has been reported. A hospital CGM program requires cooperation of physicians, bedside nurses, diabetes educators, and hospital administrators to appropriately select and manage patients. Processes for collecting, reviewing, storing, and responding to CGM data must be established for such a program to be successful. CGM technology is advancing and we expect that CGMs will be increasingly used in the hospital for patients with diabetes.http://www.e-enm.org/upload/pdf/enm-2021-201.pdfblood glucosecovid-19diabetes mellitusglucosehospitalsintensive care unitstechnology |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
M. Citlalli Perez-Guzman Trisha Shang Jennifer Y. Zhang Donna Jornsay David C. Klonoff |
spellingShingle |
M. Citlalli Perez-Guzman Trisha Shang Jennifer Y. Zhang Donna Jornsay David C. Klonoff Continuous Glucose Monitoring in the Hospital Endocrinology and Metabolism blood glucose covid-19 diabetes mellitus glucose hospitals intensive care units technology |
author_facet |
M. Citlalli Perez-Guzman Trisha Shang Jennifer Y. Zhang Donna Jornsay David C. Klonoff |
author_sort |
M. Citlalli Perez-Guzman |
title |
Continuous Glucose Monitoring in the Hospital |
title_short |
Continuous Glucose Monitoring in the Hospital |
title_full |
Continuous Glucose Monitoring in the Hospital |
title_fullStr |
Continuous Glucose Monitoring in the Hospital |
title_full_unstemmed |
Continuous Glucose Monitoring in the Hospital |
title_sort |
continuous glucose monitoring in the hospital |
publisher |
Academya Publishing Co. |
series |
Endocrinology and Metabolism |
issn |
2093-596X 2093-5978 |
publishDate |
2021-04-01 |
description |
Continuous glucose monitors (CGMs) have suddenly become part of routine care in many hospitals. The coronavirus disease 2019 (COVID-19) pandemic has necessitated the use of new technologies and new processes to care for hospitalized patients, including diabetes patients. The use of CGMs to automatically and remotely supplement or replace assisted monitoring of blood glucose by bedside nurses can decrease: the amount of necessary nursing exposure to COVID-19 patients with diabetes; the amount of time required for obtaining blood glucose measurements, and the amount of personal protective equipment necessary for interacting with patients during the blood glucose testing. The United States Food and Drug Administration (FDA) is now exercising enforcement discretion and not objecting to certain factory-calibrated CGMs being used in a hospital setting, both to facilitate patient care and to obtain performance data that can be used for future regulatory submissions. CGMs can be used in the hospital to decrease the frequency of fingerstick point of care capillary blood glucose testing, decrease hyperglycemic episodes, and decrease hypoglycemic episodes. Most of the research on CGMs in the hospital has focused on their accuracy and only recently outcomes data has been reported. A hospital CGM program requires cooperation of physicians, bedside nurses, diabetes educators, and hospital administrators to appropriately select and manage patients. Processes for collecting, reviewing, storing, and responding to CGM data must be established for such a program to be successful. CGM technology is advancing and we expect that CGMs will be increasingly used in the hospital for patients with diabetes. |
topic |
blood glucose covid-19 diabetes mellitus glucose hospitals intensive care units technology |
url |
http://www.e-enm.org/upload/pdf/enm-2021-201.pdf |
work_keys_str_mv |
AT mcitlalliperezguzman continuousglucosemonitoringinthehospital AT trishashang continuousglucosemonitoringinthehospital AT jenniferyzhang continuousglucosemonitoringinthehospital AT donnajornsay continuousglucosemonitoringinthehospital AT davidcklonoff continuousglucosemonitoringinthehospital |
_version_ |
1721484400061841408 |